Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Luminita, Pilat"'
Autor:
Daniela Mocan, Radu Ioan Lala, Maria Puschita, Luminita Pilat, Dan Alexandru Darabantiu, Adina Pop-Moldovan
Publikováno v:
Biomedicines, Vol 12, Iss 5, p 951 (2024)
Congestion not only represents a cardinal sign of heart failure (HF) but is also now recognized as the primary cause of hospital admissions, rehospitalization, and mortality among patients with acute heart failure (AHF). Congestion can manifest throu
Externí odkaz:
https://doaj.org/article/c6a1024691004b43a2223cb48c2058a4
Autor:
Andrei Ardelean, Diana-Federica Balta, Carmen Neamtu, Adriana Andreea Neamtu, Mihai Rosu, Luminita Pilat, Silviu Moldovan, Cristi Tarta, Bogdan Totolici
Publikováno v:
Diagnostics, Vol 13, Iss 14, p 2366 (2023)
Strategies have been researched and implemented to reduce the number of people with diabetic foot ulcers (DFUs). One problem is the accurate assessment of DFU severity, which is the main factor in resource allocation and treatment choice. The primary
Externí odkaz:
https://doaj.org/article/ad437d54df2b454e8de6a77c2db0d2a0
Publikováno v:
Arquivos Brasileiros de Cardiologia, Iss 0 (2016)
Abstract Background: Heart failure is accompanied by abnormalities in ventricular-vascular interaction due to increased myocardial and arterial stiffness. Galectin-3 is a recently discovered biomarker that plays an important role in myocardial and va
Externí odkaz:
https://doaj.org/article/ba8d0215042e4cc3ab488e7b60b73e3c
Publikováno v:
Revista de Chimie. 71:262-266
The aim of our study was to assess the predictive values for hypertensive complications of pregnancy of the multiples of median (MoM) of serum pregnancy associated plasma protein A (PAPP-A), measured in 128 pregnant patients between 11 and 14 weeks g
Publikováno v:
European Heart Journal - Cardiovascular Imaging. 21
Background and objectives Heart failure is responsible for high mortality rates. Galectin-3 has been suggested as a potential heart failure development and progression mediator. This study aimed to show the relationship between galectin-3 and time ev
Autor:
Ovidiu Horea Bedreag, Cristian Nicolescu, Luminita Pilat, Alaxendru Pop, Laura Nicolescu, Alin Mihu
Publikováno v:
Revista de Chimie. 69:1830-1837
This article presents an observational randomized prospective study done on 65 patients, who underwent major surgical interventions in the field of orthopedic surgery-total hip replacement or general surgery � total colectomy. The level of albumine
Publikováno v:
Herz. 43:146-155
Galectin-3 has been reported as a mediator of heart failure (HF) development and progression. Most studies, however, have been conducted on patients with chronic HF rather than acute HF (AHF). The aim of this study was to confirm galectin-3 as a prog
Autor:
Voicu, Dascau, Gheorghe, Furau, Cristian, Furau, Cristina, Onel, Casiana, Stanescu, Liliana, Tataru, Cristina, Ghib-Para, Cristina, Popescu, Luminita, Pilat, Maria, Puschita
Publikováno v:
Maedica. 12(1)
Uterine artery Doppler flow studies during the 11th and 14th week of pregnancy are important in the prediction of preeclampsia and intrauterine growth restriction in pregnant women as well as in the prevention thereof.Our study on Doppler flow indice
Publikováno v:
Arquivos Brasileiros de Cardiologia, Iss 0 (2016)
Arquivos Brasileiros de Cardiologia
Arquivos Brasileiros de Cardiologia v.106 n.2 2016
Sociedade Brasileira de Cardiologia (SBC)
instacron:SBC
Arquivos Brasileiros de Cardiologia, Volume: 106, Issue: 2, Pages: 121-129, Published: 12 JAN 2016
Arquivos Brasileiros de Cardiologia
Arquivos Brasileiros de Cardiologia v.106 n.2 2016
Sociedade Brasileira de Cardiologia (SBC)
instacron:SBC
Arquivos Brasileiros de Cardiologia, Volume: 106, Issue: 2, Pages: 121-129, Published: 12 JAN 2016
Background: Heart failure is accompanied by abnormalities in ventricular-vascular interaction due to increased myocardial and arterial stiffness. Galectin-3 is a recently discovered biomarker that plays an important role in myocardial and vascular fi
Autor:
Luminita Pilat, David Chirila, Calin Popa, Doriana Misceo, Valerica Belengeanu, Ilinca Frunza, Cristina Popescu, Monica Stoian, Viorica Leordean, Alina Belengeanu
Publikováno v:
Current Opinion in Biotechnology. 24:S97-S98